the EARTH Group § § Osteoarthritis (OA) is a leading cause of disability for which disease-modifying treatments are lacking. Anterior cruciate ligament (ACL) tear provides opportunities to study potential interventions from the initiation of heightened OA risk at the time of injury. This institutional review board (IRB)-approved prospective cross-sectional study (level of evidence: 2) was performed to test the hypothesis that adequate sample sizes of ACL-injured subjects to support randomized controlled trials (RCT) of early intervention strategies can be achieved. A total of 307 ACL-injured patients were entered into the database from 3-month collection periods at 7 clinical sites, with 65 subjects aged 18 to 30 years passing the inclusion/exclusion criteria. From sites that were IRB approved to ask, 89 of 96 (93%) subjects were willing to participate in an RCT. Extrapolating the 3-month data to a 1-year recruitment period would potentially yield 242 subjects aged 18 to 30 years willing to undergo randomization. This study shows that adequate sample sizes to perform RCT of early intervention strategies in ACL-injured cohorts comprising healthy young adults ages 18 to and 30 without prior joint injuries can be achieved within 1 to 2 years through recruitment at 5 to 7 orthopaedic sports medicine practices. Continued development of ACL-tear cohorts will provide the clinical base to critically evaluate new diagnostic and therapeutic strategies that can help transform clinical care of OA from palliation to prevention.
The evaluation, treatment, and management of anterior cruciate ligament (ACL) injuries have been a priority for members of the American Orthopedic Society for Sports Medicine (AOSSM) since its inception. 1, 6 Although ACL reconstruction has been successful in returning patients to high-level sport, physically demanding work, and active lifestyles, early-onset disabling osteoarthritis (OA) after ACL tear remains an unsolved clinical problem. 4, 8, 10 Preclinical animal studies show high potential to delay osteoarthritis onset through interventions used early in the disease process such as shortly after ACL transection. 7, 13 Similar to these animal models, ACL tears increase the risk of OA and provide opportunities to study human OA pathogenesis as well as potential interventions from a known start date. 2 In 2008 and 2010, the AOSSM organized 2 National Institutes of Health (NIH)-funded multidisciplinary ''Post-joint Injury Osteoarthritis'' conferences to focus the osteoarthritis research and clinical communities onto the unique opportunities afforded by ACL tear cohorts for clinical research into OA pathogenesis and interventions. 1, 2 This study was performed to test the hypothesis that adequate sample sizes of human ACL-injured cohorts to support randomized controlled trials (RCT) of early and acute intervention strategies can be achieved at 5 to 7 orthopaedic sports medicine practice sites.
METHODS
Following approval by the American Orthopedic Society for Sports Medicine Board of Directors and institutional review board (IRB) approval from the University of Pittsburgh to serve as the coordinating site, the study was publicized and the opportunity to participate was provided to the AOSSM membership by e-mail newsletter and through flyers posted at the 2011 AOSSM Annual Meeting. AOSSM members from 31 sites responded, and 27 sites initiated IRB and data use agreements (DUA). At the time of the 2012 AOSSM Annual Meeting in July 2012, investigators from 7 clinical sites had obtained IRB approval and DUA and completed prospective data collection and entry concerning ACL injuries treated in their practices over a 3month period. The 3-month data collection period varied by site because of differential timing of IRB/DUA approvals and individual site conditions. The clinical performance sites composing this prospective cross-sectional study The inclusion and exclusion criteria were as follows. Those eligible for inclusion were patients between 14 and 60 years of age with a diagnosed ACL injury as established by the treating physician. Exclusion criteria included prior knee injury or surgery in either knee, posterior cruciate ligament injury, posterolateral corner injury, lateral collateral ligament injury, diabetes or other systemic disease, and history of inflammatory arthritis or gout.
The information collected included patient age, sex, height/weight/body mass index (BMI), time between ACL tear and orthopaedic evaluation, time between ACL tear and surgery, concomitant injuries, whether diagnostic magnetic resonance imaging (MRI) was obtained, and the field strength of the MRI. The IRB at 4 sites granted approval to obtain patient responses to the following 2 questions: (1) Would you be willing to participate in a randomized controlled clinical trial? and (2) Would you be willing to have your joint aspirated in the clinic? A secure, Internet-based point-of-service data entry system was developed by the University of Pittsburgh Center for Research on Health Care's Data Center and used for data collection.
RESULTS
A total of 307 ACL-injured patients were entered into the database over 3-month collection periods from 7 clinical performance sites. Nearly half of the subjects had 1 or more exclusions, leaving 157 (51%) eligible subjects for analysis. The number of eligible subjects entered into the database during the 3-month collection periods ranged from 4 to 53, with 5 sites reporting 15 or more patients meeting inclusion and passing exclusion criteria.
Demographics
The majority of eligible subjects were young, with 124 of 157 (79%) younger than 40 years of age, 97 (62%) younger than 30 years, and 65 (41%) ages 18 to 30 years. Overall, 83 of 157 (53%) were male and 74 (47%) were female. The percentage of injuries for each sex varied by age, with females making up 23 of 32 (72%) ACL injuries in ages 14 to 17 years, 28 of 65 (43%) in ages 18 to 30 years, and 9 of 28 (32%) in ages 31 to 40 years ( Figure 1 ). The mean 6 standard deviation BMI was 26.4 6 5.9, with males at a mean of 27.6 65.1 and females at a mean of 25.0 66.4.
Timing of Orthopaedic Evaluation and Reconstructive Surgery
Among eligible subjects, 36 of 157 (23%) saw an orthopaedic surgeon within 48 hours of injury, 77 (49%) were seen within 1 week of injury, and 118 (75%) were seen within 1 month of injury ( Figure 2 ). More than 50% of eligible subjects were seen within 48 hours of injury at 2 sites, and more than 50% of eligible subjects were seen within 1 week at 3 sites. At the 5 sites entering 15 or more eligible subjects into the database during the 3-month collection period, 114 of 147 (78%) were seen within 1 month of injury. Overall, reconstructive surgery was performed in 29% of eligible subjects within 6 weeks of injury and in 50% within 3 months of injury.
Concomitant Injuries
Concomitant injuries in eligible subjects included 80 of 157 (51%) with bone bruises, 79 (50%) with meniscal tears, 33 (21%) with MCL injuries, and 7 (4%) with cartilage injuries. Of the 79 subjects with meniscal tears, 37 (47%) were medial meniscal tears, 23 (29%) were lateral meniscal tears, and 19 (24%) tore both menisci.
Willingness to Participate in Research and Diagnostic MRI
From the 4 sites with IRB approval to ask eligible subjects about randomization and aspiration, 89 of 96 (93%) answered ''yes'' to the question on whether they would participate in an RCT and 62 of 96 (65%) answered ''yes'' to the question on undergoing knee aspiration in the clinic. Diagnostic MRI was common in this population, with 152 of 157 (97%) receiving an MRI. Of the MRI scans performed, 114 (75%) were on a 1.5-T MRI scanner and 12 (8%) were on a 3.0-T MRI scanner.
Power Analysis
Extrapolating the 3-month data to cover a 1-year recruitment period targeting young adults aged 18 to 30 years (n = 65) who meet the inclusion and pass the exclusion criteria at all 7 sites would yield an estimated 260 (65 3 (Table 1) . A highly controlled cohort would be composed of healthy young adults aged 18 to 30 years seen within 1 week of ACL injury passing the exclusion criteria. Thirty-four patients meeting these rigorous criteria were enrolled at the 5 sites entering 15 or more eligible subjects within the 3-month reporting periods. This would yield an estimated 136 (34 3 4) subjects, of which an estimated 126 (93%) would be willing to undergo randomization. With 80% retention at 2-year follow-up, this would provide 100 subjects for analysis, which would provide 80% power to determine an effect size of 0.6 with significance set at P \ .05 (Table 1) . A 2-year recruitment period would potentially yield 272 subjects, of which an estimated 252 (93%) would agree to participate. With 80% retention at 2-year follow-up, 202 would be available for analysis, which would provide 80% power to determine an effect size of 0.4 with significance set at P \ .05 (Table 1) .
These sample sizes compare favorably with cohorts of 188 and 180 used in 2 high-impact RCTs that evaluated arthroscopy for the treatment of knee OA and established the efficacy of etanercept for treatment of rheumatoid arthritis, respectively. 9, 12 They additionally exceed sample sizes needed to detect effect sizes of 0.5 and 0.8 at both 80% and 90% power with significance set at P \ .05 (Table 2) .
Using actual clinical data from a recent study employing a new quantitative MRI metric known as ultrashort echo time enhanced T2* (UTE-T2*) mapping to evaluate the menisci in ACL-injured subjects, an effect size of 1.2 was observed in subsurface measures of morphologically intact menisci compared to torn menisci in ACL-injured subjects. 14 The sample sizes generated in this study greatly exceed the 24 to 36 subjects needed to provide 80% power with significance set at P \ .05 to determine effect sizes of 1.2 discernible clinically in menisci of ACLinjured subjects using this new metric ( Table 2) . 
DISCUSSION
This study shows that the clinical research potential exists within 5 to 7 orthopaedic sports medicine practices to support RCTs of acute and early intervention strategies in ACL-injured cohorts composed of healthy young adults between 18 and 30 years of age without prior knee or joint injuries. Because nearly a quarter of eligible subjects were seen within 48 hours of injury and close to one-half were seen by 1 week of injury at the participating sites, the data also demonstrate feasibility in performing intervention studies where treatment is initiated within a few days of injury. That this clinical potential was demonstrated in just 7 sites across the country further highlights the research interest and clinical feasibility within the orthopaedic sports medicine community for these types of studies. The data are from a select group of orthopaedic sports medicine practices volunteering for a feasibility study involving acute ACL injuries. As such, these data cannot be considered fully reflective of the acuity in care or epidemiology of ACL-injured patients in general. Because of strict inclusion and exclusion criteria, nearly half the subjects identified at the clinical performance sites as potentially eligible were excluded. However, some important observations on age and sex deserve mention. Consistent with other reports, the patients were young. 6 While the overall ratio of males to females was similar, more than two-thirds of high school-aged ACL-injured subjects in this study were female, reflecting a trend also seen in a large managedcare population. 3 Given the increased OA risk associated with ACL injuries, the higher risk for knee injuries in female athletes, and the greater incidence of OA in older women, these data further highlight the importance of injury prevention and awareness programs in youth sports and especially in teenage women. Prevention of ACL and meniscal injury will be critical to reducing OA risk and preventing early-onset OA in these populations.
While the results are promising, this is a feasibility study with limitations. Of the 96 subjects asked about willingness to participate in a randomized clinical trial, 93% answered affirmatively. Because the question was hypothetical without details concerning the proposed intervention or the nature, invasiveness, and time commitments on the part of subjects for follow-up evaluations, it is likely that enrollment rates for an actual trial may be lower. As well, the annual estimates may be high because of seasonal variability in ACL injuries at some sites that are not captured in a 3-month data collection period. These variables can be addressed during planning for an actual clinical trial through analysis of annual practice patterns as well as selection of sites meeting annual minimal volume and injury acuity criteria for the intervention to be studied. With development of more sensitive metrics for outcomes assessments, such as the UTE-T2* quantitative MRI measures used in the sample analysis, 14 the potential subject numbers obtained during the 3-month collection periods in this study are greater than what may be needed in the future for pilot and proof of concept studies. In contrast to RCTs involving actual surgical procedures or surgery compared with no surgery, 5,11 subject enrollment, followup, and data analysis for studies of OA prevention strategies will likely be similar to what has been achievable with medical and physical treatments. 11, 12 Overall, feasibility to perform RCT involving young adults 18 to 30 years old with acute ACL injuries was established. Whereas recruitment to enter 188 subjects for a single-center RCT on knee arthroscopy and osteoarthritis took 6 years, sufficient numbers of eligible subjects were evaluated at 5 to 7 clinical sites to potentially support adequate recruitment of a comparable number of subjects meeting highly selective criteria within 1 to 2 years. Multicenter RCT involving 5 to 7 clinical performance sites is manageable. 12 In summary, this study shows that the clinical research potential exists within 5 to 7 orthopaedic sports medicine practice sites to support randomized clinical trials involving young adults with acute ACL injuries. Although much work still needs to be done developing and validating quantitative measures to evaluate the natural history of the ACL-injured knee, this human clinical cohort with key similarities to the commonly used ACL transection animal model of OA offers new potential for bringing OA prevention strategies to human disease. Continued characterization of the potential to develop well-defined multicenter ACL tears and other joint injury cohorts will provide the clinical research base to critically evaluate new diagnostic and therapeutic strategies that can help transform clinical care of OA from palliation to prevention.
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